chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Seizure at school, patient was unable to speak coherently, only weird sounds would come from her mouth. She had a second seizure at home and she was on the floor and unable to talk properly. She was not able to control her arms, legs or face and could not drink water. After some time she became normal. We have never see this happen in the last 12 years. She had been having anxiety symptoms for the last 3 months however family ignored it thinking it was not something significant.
Broke out in rash last night on back and mouth, turning over course of day to blisters. Advised to use aveeno bath, benadyl cream and tylenol if fever.
I experienced the normal flu like symptoms. Fever, chills, body aches along with that I had chest pain. My chest pain was sharp, stabbing pain that comes and goes, intermittently. I am on day 24 with chest pain. I was referred to the heart doctor, they did an EKG which was normal. MY PCP did a tri-triponent blood test was normal, an also ordered a D-dimmer and it was elevated, i was sent to ER to check for pulmonary embolism which was clear. Another EKG was done and it was normal. My electrolytes were normal. I had stress test this morning 04-14-2021. My PCP ordered platelets due to my left leg pain and heavy feeling and burning feeling that comes and goes. My platelets were normal. My WBC is very low and  I have an echocardiogram scheduled on Monday. The ER doctor said that the vaccine caused the inflammation on my body and my chest, having an auto-immune reaction.  I still have chest pain.
Pain and a little throbbing after 4 weeks from the 2nd vaccine; This is a spontaneous report from a contactable other hcp (patient, self-reporting). A 57-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: ER2613), dose 2 via intramuscular route of administration in arm left on 13May2021 at 17:00 as single dose (age at vaccination 57-year-old) for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Historical vaccine information included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number EWO172), 1st dose (age at vaccination 57-year-old) on 22Apr2021 at 04:30 PM administration site left arm for COVID -19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. No known allergies. other medication includes VITAMINS. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient was not pregnant at the time of vaccination. The patient experienced pain and a little throbbing after 4 weeks from the 2nd vaccine on 14May2021. No treatment was given for events. The outcome for event was not recovered.  Follow-Up (27Jul2021): Follow-up attempts are completed. No further information is expected.
Fever of 101.3 and chills Sat night, exhaustion, slight nausea a little on Sat evening before fever, headache, achy all over and overall feeling not well, swollen, red and itchy at sight of injection (started really swelling by Sat evening and swollen and red approx 3.5 cm in diameter by Monday). Headache worse on same side as injection and scalp pain on same side of injection. Fever and chills gone by Sunday morning. Allergy feeling in eyes and throat by Monday and "feeling of throat closing a little". Lower arm beginning to itch by Mon. Finally took a BENADRYL Monday. Redness/swelling decreasing in arm (still about 3 cm), itchiness at site has lessened and pain is pretty much gone but still sore, eyes and throat are a little better, achiness is almost gone, headache is almost gone, no more body aches, scalp pain and sensitivity almost gone within 12 hours of taking 1 BENADRYL. Seem to have a loss of appetite.
Pt recvd 3 doses of Engerix-B & following dose exp severe flu-like sx for 24 hrs p/inject;
Local erythma, swelling and itchiness in 3x5 area, L) upper arm, adjacent to site Tdap & Menactra injection.
Pregnant caller received the 1st dose of the moderna vaccine; This spontaneous retrospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Pregnant caller received the 1st dose of the moderna vaccine) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported. ).    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 08-Oct-2021. On 17-Mar-2021, the patient experienced EXPOSURE DURING PREGNANCY (Pregnant caller received the 1st dose of the moderna vaccine). On 17-Mar-2021, EXPOSURE DURING PREGNANCY (Pregnant caller received the 1st dose of the moderna vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided.  This is a case of product exposure during pregnancy with no associated AEs for this 33-year-old female patient. Patient will continue to be contacted for further monitoring of AEs during the pregnancy.; Sender's Comments: This is a case of product exposure during pregnancy with no associated AEs for this 33-year-old female patient. Patient will continue to be contacted for further monitoring of AEs during the pregnancy.
PATIENT CAME TO THE PHAMACY CONCERNED ABOUT HER ARM BEING RED/SWOLLEN/SOFTBALL LIKE RASH NEAR HER INJECTION SITE.
Maculopapular rash, low grade fever 12 day s/p MMR:
Fever of 101, Chills, Body Aches.  Used Ibuprofen and Tylenol
Headache for a week ending in brain bleed. Went to er, found to have hypoxia, pneumonia PNA
C/O pain, itchy today 6/9/11 (L) leg swollen from upper thigh to knee with red blotches upper lateral thigh. Location of injection site.
Lightheadedness; Arm was in pain for 2 days; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Lightheadedness) and PAIN IN EXTREMITY (Arm was in pain for 2 days) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A) for COVID-19 vaccination.     Concurrent medical conditions included COVID-19 (Recovering), Diabetic and Hypertension.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced DIZZINESS (Lightheadedness) and PAIN IN EXTREMITY (Arm was in pain for 2 days). The patient was treated with METFORMIN at an unspecified dose and frequency; GLIPIZIDE at an unspecified dose and frequency and APPLE CIDER VINEGAR at an unspecified dose and frequency. At the time of the report, DIZZINESS (Lightheadedness) and PAIN IN EXTREMITY (Arm was in pain for 2 days) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood glucose: high (High) Very high sugar levels in the range of 200.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were provided.  The patient reported that the symptoms started about a week after taking the shot. The patient stated that she tried metformin, and glipizide and it did not work but apple cider vinegar was taking it down. The symptoms were ongoing at the time of reporting.
04/06/05- c/o temp 101 degrees, relieved with Tylenol: itchiness and rash. 04/18/2005- c/o rash noted to axilla bilaterally, red blotches and temp, with increased itchyness. RX Betamethasone dipronate x 1 week
AUG 4 - fatigue, diplopia, loss of OD medial gaze. AUG 5,6 - photosensitivity, headache, problems focusing. AUG 7 - left eye drifting, loss of OD medial gaze -> to ER; normal CT/MRI head. AUG 9 - ophtho consult - OD 3rd nerve palsy, OD exotropia hypertropic.
Information has been received from a pharmacist and refers to a patient of unknown age and gender. There was no information about patient's concurrent conditions, medical history or concomitant medications. On 25-SEP-2017, the patient was vaccinated with a dose of improperly stored  rotavirus vaccine, live, oral, ZOSTAVAX lot # N021171 and expiration date of 01-NOV-2018, (route of administration and anatomical location were not reported), for prophylaxis, which was stored in the range of 6 Fahrenheit degrees to 14 Fahrenheit degrees for 45 minutes.  No previous temperature excursion was reported.  No adverse effects were reported. Digital data logger was involved.
Information has been received from a nurse practitioner concerning a 19 year old female patient who 1.5 year ago, approximately in July 2007, was vaccinated with the first dose of GARDASIL vaccine 0.5 mL IM.  Approximately thirty days after received GARDASIL vaccine, in approximately August 2007, the patient experienced bilateral facial pain, numbness of her feet and hands, pain in her hands and gastrointestinal upset.  It was noted
This spontaneous report was received from a pharmacist regarding a patient of unknown age and gender. Information on the concurrent condition, medical history and pertinent drug allergies of the patient were not reported. On 13-NOV-2015 at time- 18:38, the patient was vaccinated with improperly stored RECOMBIVAX HB lot # L016427 (expiry date, dose #, route, dose units and anatomical location were not specified). Concomitant medication was not reported. No adverse event were reported. The high temperature and low temperature at which the product was stored were 3.6 and 2.8 (units unspecified) respectively. There were no Product Quality Complaint (PQC) involved. This is one of several reports received from the same reporter. Additional information has been requested.
Information has been received from a physician concerning a 12 month old twin male with pneumonia and no allergies who on 02-AUG-2007 at approximately 15:00 was vaccinated SC on the right arm with a first dose of VARIVAX (lot # 658024/0833U). Concomitant therapy included a first SC dose on left arm of MMR II (Lot # 655414/1470F) and a fourth IM dose on left thigh of PREVNAR with no previous adverse experiences related to it. It was reported that on 10-AUG-2007 the patient experienced seizure. Unspecified medical attention sought. A chest x-ray was done (results not reported). At the time of report the patient had recovered. A product quality complaint was not involved. The patient's twin brother had similar experience after therapy with VARIVAX (WAES # 0709USA00135). Additional information has been received from the physician who stated that the patient had seizure 1 week after vaccination on 10-AUG-2007 at approximately 10:00 AM. The patient had febrile seizure (also reported as seizure), 15 minutes after his twin brother had same experience. At the time of report the patient had recovered. Upon internal review seizure was considered to be an other important medical event. No further information is expected.
Patient experienced hives on head and neck within about 10 minutes of receiving covid vaccine. Allegra given. He had no additional complaints. Vitals stable. Wife at patient's side.
AFTER VACCINES CLIENT STATED HE DID NOT FEEL WELL. NOTED COLOR WAS PALE. CLIENT'S HEAD WAS LOWERED BETWEEN LEGS, AMMONIA CAPSULE WAS PLACED UNDER CLIENT NOSE. NOTED CLIENT BECAME LIMP AND HIS HANDS AND FEET TURN INWARD AND STIFFENED AND EYE PUPILS FIXED. 911 WAS CALLED AND ICE PACK PLACED TO BACK OF NECK. CLIENT BECAME ALERT AND LAID DOWN WITH LEGS ELEVATED. B/P 120/80. EMS EVALUATED CLIENT B/P 139/72. CLIENT GRANDPARENTS DECLINED TO SEND CLIENT TO HOSPITAL. CLIENT STATED HE FELT BETTER AND AMBULATED OUT OF CLINIC
Tingling sensation all over progressing to feeling hot.  This resolved in 30 - 40 minutes.  She then experienced pressure in her abdomen approximately one hour after injection and she re-presented to the Vaccine Clinic.  This resolved.
Systemic: Confusion-Mild, Systemic: Dizziness / Lightheadness-Medium, Systemic: Flushed / Sweating-Mild, Additional Details: Under pharmacist observation for 45 minutes , fainted and light-headed 5 minutes, given bottle water for hydration .  no other symptoms and fine after 45 minutes of observation
Information has been received from a lawyer regarding a case in litigation concerning a male patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient's healthcare provider recommended and/or prescribed ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. On or about 2011, a healthcare provider administered the ZOSTAVAX to the patient (lot number, dosage and route of administration not provided). On or about 27-OCT-2016, the patient was treated by a healthcare provider at a hospital for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX vaccine, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death; aggravation of preexisting conditions and activation of latent conditions (unspecified); lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was considered to be not recovered. Additional information has been requested.
I woke up in the morning with head congestion and a headache. On the 2nd day, the headache and congestion increased. I was driving for 6 hours and became so tired from being sick I pulled over and slept on the side of the road for an hour and a half. I had a continuous headache and slight fever for about 5 days. I was tested on the 3rd since my symptoms were not getting better. I was notified via the medical portal and was given instructions on what to do. There was a level of fatigue up until last week. I isolated for 10 days.
The pt developed osteomyelitis and septic right ankle. Child immunized with three doses of pneumococcal conjugate vaccine on 1/01/2001, 04/03/2001 and 06/05/2001.
pt stated that 2-3days p/vax pt exp local swelling & felt warm & stated all muscles stiffened up & although stiffness noted states that has episode tingling in all extremities;also had rash on body 2-3 days post vax;
Head ache,   Fever,  Flu like symptoms  1st shot had no symptoms,   2nd shot was the adverse event Missed two days of work
Two months after vaccine, I felt a tightness in chest and radiated in jaw. I went to ER. I was hospitalized - two nights. It was a specialized kind of heart attack. It was a heart spasm. Takotsubo Cardiomyopathy. Heparin IV and nitroglycerine IV at hospital. Treated with medication went released to go home. I'm on five meds: Lipitor; Cozaar; Toprol XL; Nitroglycerin as needed ( I haven't need it); baby aspirin. Been symptom free since then.
day p/vax pt devel 24hr of mild flu-like sx & painful lump at inject site
Area on L/Deltoid swelled up approximatly the size of a nickle.  Bruising and swelling started the next day following vaccination.  Joint ache with a slight fever also was experienced.
Patient came in and received the vaccine before her age was verified. Patient was instructed to wait the 30 minutes o make sure that there was no adverse reaction. Patient had no reaction to the vaccine and left the facility. Staff was retrained on verifying the age before any vaccine is given in the facility.
tightening sensation in throat air way restricting; tightening sensation in throat air way restricting; Taste in mouth followed by burning sensation throughout my body; Taste in mouth followed by burning sensation throughout my body; Turned red skin hot to touch; Turned red skin hot to touch; This is a spontaneous report from a contactable consumer (patient). A 56-years-old female patient received BNT162B2 (Brand: Pfizer), dose 2 via an unspecified route of administration, administered in arm right on 13Apr2021 (Lot Number: EW0158) as single dose for COVID-19 immunisation. Medical history included asthma and high blood pressure. Known allergies: Sulfa drugs. If Covid prior vaccination: No. If Covid tested post vaccination: No. The patient was not pregnant. The patient's concomitant medications were not reported. If other vaccine in four weeks: No. The patient previously received first dose of BNT162B2 on 23Mar2021 01:15 PM (Lot number: ER5732), in left arm, at the age of 56-year-old for COVID-19 immunization. 1st shot hot spot red swelling at injection area. 2nd shot severe instant adverse reaction. The patient experienced taste in mouth followed by burning sensation throughout her body. Turned red skin hot to touch. Immediately followed by tightening sensation in throat air way restricting on 13Apr2021 at 01:45 AM. The events resulted in: Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Life threatening illness (immediate risk of death from the event). Treatment was received for the events which included Medics treated oxygen Dr administered Benadryl. The patient was recovering from the events.
This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a elderly female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, unknown after receiving SHINGRIX, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was unknown. It was unknown if the reporter considered the injection site pain to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient concerned that her 1st shot did not create an issue except the soreness of the shot. This case has been linked to the case US2019GSK059779.
Ascites/Fluid Buildup Around His Stomach; Stomach ache; This is a spontaneous report from a non-contactable consumer from the Project: COVID-19 Vaccine Social Media Monitoring. A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot number was not reported), via an unspecified route of administration, on an unspecified date, as dose number unknown, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. It was stated that, after COVID Vaccine, on an unspecified date, the patient experienced ascites, fluid buildup around his stomach and could not fight and also experienced stomach ache. The outcome of the events was unknown.  Follow-up attempts are possible; information about lot/batch number can be obtained.
This case was reported by a physician via call center representative and described the occurrence of influenza-like symptoms in a 58-year-old male patient who received SHINGRIX for prophylaxis. On 13th July 2018, the patient received SHINGRIX (intramuscular) .5 ml. On 14th July 2018, 1 days after receiving SHINGRIX, the patient experienced influenza-like symptoms, chills, muscle pain, fever and headache. On an unknown date, the outcome of the influenza-like symptoms, chills, muscle pain, fever and headache were not recovered/not resolved. It was unknown if the reporter considered the influenza-like symptoms, chills, muscle pain, fever and headache to be related to SHINGRIX. Additional details were reported as follows: The physician reported that the patient experienced side effects with SHINGRIX. Patient experienced symptoms the day after the injection and was still having all the symptoms as of the day of reporting. Transferred to Medical Information for follow up discussions.
Pt received Pfizer Peds dose (0.2 ml) but he is 12 years old and indicated for regular Pfizer dose. He received regular Pfizer for dose 1 but incorrectly received Peds for dose 2. No current issues, symptoms, or signs have been reported.
given expired doses; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 18-month-old female patient who received HAV (Havrix) (batch number 3HR79, expiry date 16th September 2021) for prophylaxis.   Co-suspect products included hepatitis A vaccine pre-filled syringe device (Havrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 6th October 2021, the patient received Havrix and Havrix Pre-Filled Syringe Device. On 6th October 2021, unknown after receiving Havrix and Havrix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The patient had been given expired doses of the Havrix vaccine, which led to expired vaccine used. The patient consented to follow up by email. This case has been linked to US2021208268, reported by the sane reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021208268:same reporter
This spontaneous report was received from a physician referring to a patient of unknown age and gender. The concurrent conditions and medical history were not provided. On 29-JAN-2016, the patient was vaccinated with an improperly stored dose of ZOSTAVAX, (route and dose were not provided) Lot#: L037797, expiration date on 30-DEC-2016. Concomitant therapies were not provided. No adverse events were reported. No product quality issue was involved. Additional information is not expected, since no permission for further contact was given.
a week of not feeling good every single time I receive the Pfizer COVID vaccine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 61-year-old female patient received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE NMBER UNKNOWN, SINGLE; Lot number: unknown), for Covid-19 Immunization, reaction(s): "a week of not feeling good every single time I receive the Pfizer COVID vaccine". The following information was reported: FEELING ABNORMAL (non-serious), outcome "unknown", described as "a week of not feeling good every single time I receive the Pfizer COVID vaccine".  Additional information: Reporter did not want warm-transfer to DSU as caller stated she had already reported her side effects when she first got the Pfizer COVID shots and did not want to report again. Caller stated that it was a week of not feeling good every single time she received the Pfizer COVID vaccine. Caller was asking if the new shot will not have a side effect. Caller mentioned that when she took the last booster shot a couple of years ago, it gave a terrible side effect. She stated that she went to the website and couldn't find side effects to the new Pfizer COVID vaccine for 12 years of age and older as it was still talking about the old shot.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.